Macrogen Inc

Chart & Performance

D1W1MN

P/E

59.38

P/S

0.62

EPS

203.43

Div Yield, %

2.56%

Shrs. gr., 5y

1.60%

Rev. gr., 5y

11.64%

Revenues

195.27b

+43.82%

Net income

2.03b

CFO

21.50b

+201.87%

Dividend

Dec 29, 2025300 KRW/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Macrogen, Inc. specializes in offering a wide array of services within genetic research and biotechnology. Their core offerings span various solutions, including whole-genome, clinical, and personalized DNA sequencing, as well as oligonucleotide synthesis, microarray analysis, and the creation of genetically engineered mice. This company was established on June 5, 1997, and its corporate headquarters are situated in Seoul, South Korea.

URL

http://www.macrogen.com

IPO date

Feb 22, 2000

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title KRW in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title KRW in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT